Mergers and Acquisitions

Pages

Sprint, T-Mobile resume merger discussions

Mar 9, 2011
Stock prices jumped yesterday on the announcement that Sprint and T-Mobile resumed discussions of a merger. A merger of the two companies would combine the third- and fourth-largest U.S. wireless providers.
Posted In: Mergers and Acquisitions

Luxury goods giant buys a piece of watchmaker Bulgari

Mar 7, 2011
LVMH owns luxury brands from Louis Vuitton to Moet champagne and it now plans to sell watches. It will acquire a major piece of Italian jeweler Bulgari for $5.2 billion. Stephen Beard explains.
Posted In: Mergers and Acquisitions, Retail

Blackstone to buy almost 600 shopping centers

Feb 28, 2011
Betting on American consumers and rebounding property prices, private equity investor Blackstone Group is to buy nearly 600 shopping centers.
Posted In: Mergers and Acquisitions, Retail

MID-DAY UPDATE: stock exchange merger, Egypt, workers' union, and Civil War tourism

Feb 18, 2011
Now that the German and New York stock exchanges have tied the knot, it's time to discuss which entity is going to take a new name. Germans think...
Posted In: Civil War, Egypt, Facebook, Germany, Hosni Mubarak, Mergers and Acquisitions, mid-day update, National Park Service, New York, NYSE, stock market, stocks, tourism

Newly merged stock exchanges search for a new name

Feb 18, 2011
The combined German and New York Stock Exchange must now find a suitable name for the newly merged trading floor. And as Stephen Beard explains, instead of using a brand consultant, the new exchange is going the social media route for suggestions.
Posted In: Mergers and Acquisitions

Sanofi-Aventis to pay more than $20 bil. for Genzyme

Feb 16, 2011
French pharmaceutical company Sanofi-Aventis will pay more than $20.1 billion for U.S. biotech firm Genzyme. Sanofi will pay $74 per Genzyme share once the deal closes in the second quarter of 2011.
Posted In: Health, Mergers and Acquisitions, Science

Pharma deal: French Sanofi-Aventis to buy U.S. Genzyme

Feb 16, 2011
Wednesday brought an end to the long-awaited deal between French pharmaceutical company Sanofi-Aventis and the U.S. biotech firm Genzyme. Sanofi will buy Genzyme for at least $20.1 billion. But the number could go higher if Genzym's drugs-in-development succeed when they go to market, as Eve Troeh explains.
Posted In: Health, Mergers and Acquisitions, Science

New York Stock Exchange agrees to merge with Deutsche Borse

Feb 15, 2011
The parent company for the New York Stock Exchange has agreed to a merger with Germany's Deutsche Borse, pending regulatory approval. The deal will create the largest exchange for stocks and derivatives in the world. Heidi Moore explains.
Posted In: Mergers and Acquisitions

U.S. panel may block Huawei-3Leaf deal, report says

Feb 14, 2011
The Wall Street Journal reports a U.S. government panel will recommend that President Obama veto a bid by China's Huawai Technologies Co. to buy the assets of Bay Area developer 3Leaf Systems. Rob Schmitz reports.
Posted In: China, Mergers and Acquisitions

The fast pace of change at the New York Stock Exchange

Feb 10, 2011
Kai Ryssdal talks to Teddy Weisberg, the president of Seaport Securities, about the potential merger of the New York Stock Exchange with Germany's Deutsche Borse AG.
Posted In: Mergers and Acquisitions, Wall Street

Pages